ID Biomedical Opens Channel For Fluviral Distribution in U.S.
Executive Summary
Henry Schein has committed to purchasing approximately half of all ID Biomedical Fluviral doses produced for the U.S. under a distribution agreement for the flu vaccine unveiled by the companies Dec. 6